Shedding Light on Persistent Immune Thrombocytopenia Immune thrombocytopenia is a serious hematological condition that can result in life-threatening bleeding. When it persists for 3 to 12 months following initial treatment, it is termed persistent immune thrombocytopenia (PITP). Patients with PITP are most at risk of bleeding if they have hypertension, renal insufficiency, are on an anticoagulant or antiplatelet agent, are at risk for trauma, or cannot tolerate corticosteroids. Read more. |
Follicular Lymphoma Treatment Benefits Older Patients Follicular lymphoma (FL) most often affects older adults, who are at increased risk of drug toxicity. Yet, not much is known about the efficacy and tolerability of these medications in this age group because they are often excluded from clinical trials or there are an insufficient number of older adults in these trials to draw meaningful conclusions. Read more. |